Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis
- PMID: 17234886
- PMCID: PMC1770903
- DOI: 10.1101/gad.406207
Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis
Abstract
TRF2 is a telomere-binding protein with roles in telomere protection and telomere-length regulation. The fact that TRF2 is up-regulated in some human tumors suggests a role of TRF2 in cancer. Mice that overexpress TRF2 in the skin, K5TRF2 mice, show critically short telomeres and are susceptible to UV-induced carcinogenesis as a result of deregulated XPF/ERCC1 activity, a nuclease involved in UV damage repair. Here we demonstrate that, when in combination with telomerase deficiency, TRF2 acts as a very potent oncogene in vivo. In particular, we show that telomerase deficiency dramatically accelerates TRF2-induced epithelial carcinogenesis in K5TRF2/Terc-/- mice, coinciding with increased chromosomal instability and DNA damage. Telomere recombination is also increased in these mice, suggesting that TRF2 favors the activation of alternative telomere maintenance mechanisms. Together, these results demonstrate that TRF2 increased expression is a potent oncogenic event that along with telomerase deficiency accelerates carcinogenesis, coincidental with a derepression of telomere recombination. These results are of particular relevance given that TRF2 is up-regulated in some human cancers. Furthermore, these data suggest that telomerase inhibition might not be effective to cease the growth of TRF2-overexpressing tumors.
Figures







Similar articles
-
XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer.Nat Genet. 2005 Oct;37(10):1063-71. doi: 10.1038/ng1633. Epub 2005 Sep 4. Nat Genet. 2005. PMID: 16142233
-
XPF with mutations in its conserved nuclease domain is defective in DNA repair but functions in TRF2-mediated telomere shortening.DNA Repair (Amst). 2007 Feb 4;6(2):157-66. doi: 10.1016/j.dnarep.2006.09.005. Epub 2006 Oct 18. DNA Repair (Amst). 2007. PMID: 17055345
-
Human XPF controls TRF2 and telomere length maintenance through distinctive mechanisms.Mech Ageing Dev. 2008 Oct;129(10):602-10. doi: 10.1016/j.mad.2008.08.004. Epub 2008 Sep 4. Mech Ageing Dev. 2008. PMID: 18812185
-
No DDRama at chromosome ends: TRF2 takes centre stage.Trends Biochem Sci. 2015 May;40(5):275-85. doi: 10.1016/j.tibs.2015.03.003. Epub 2015 Apr 3. Trends Biochem Sci. 2015. PMID: 25845889 Review.
-
Mechanisms of telomeric instability.Cytogenet Genome Res. 2008;122(3-4):308-14. doi: 10.1159/000167817. Epub 2009 Jan 30. Cytogenet Genome Res. 2008. PMID: 19188700 Review.
Cited by
-
Telomeres in aging and disease: lessons from zebrafish.Dis Model Mech. 2016 Jul 1;9(7):737-48. doi: 10.1242/dmm.025130. Dis Model Mech. 2016. PMID: 27482813 Free PMC article. Review.
-
Radiation damage and radioprotectants: new concepts in the era of molecular medicine.Br J Radiol. 2012 Apr;85(1012):313-30. doi: 10.1259/bjr/16386034. Epub 2012 Jan 31. Br J Radiol. 2012. PMID: 22294702 Free PMC article.
-
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells.Nat Cell Biol. 2013 Jul;15(7):818-28. doi: 10.1038/ncb2774. Epub 2013 Jun 23. Nat Cell Biol. 2013. PMID: 23792691
-
Upregulation and CpG island hypomethylation of the TRF2 gene in human gastric cancer.Dig Dis Sci. 2010 Apr;55(4):997-1003. doi: 10.1007/s10620-009-0810-8. Epub 2009 Apr 28. Dig Dis Sci. 2010. PMID: 19399616
-
Telomere DNA damage signaling regulates cancer stem cell evolution, epithelial mesenchymal transition, and metastasis.Oncotarget. 2017 Sep 16;8(46):80139-80155. doi: 10.18632/oncotarget.20960. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113290 Free PMC article.
References
-
- Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., DePinho R.A., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., DePinho R.A., Lee S.L., Alson S., Gottlieb G.J., Chin L., DePinho R.A., Alson S., Gottlieb G.J., Chin L., DePinho R.A., Gottlieb G.J., Chin L., DePinho R.A., Chin L., DePinho R.A., DePinho R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000;406:641–645. - PubMed
-
- Balmain A., Ramsden M., Bowden G.T., Smith J., Ramsden M., Bowden G.T., Smith J., Bowden G.T., Smith J., Smith J. Activation of the mouse Harvey-ras gene in chemically induced benign skin papillomas. Nature. 1984;307:658–660. - PubMed
-
- Bechter O.E., Zou Y., Walker W., Wright W.E., Shay J.W., Zou Y., Walker W., Wright W.E., Shay J.W., Walker W., Wright W.E., Shay J.W., Wright W.E., Shay J.W., Shay J.W. Telomeric recombination in mismatch repair deficient human colon cancer cells and telomerase inhibition. Cancer Res. 2004;64:3444–3451. - PubMed
-
- Biroccio A., Rizzo A., Elli R., Koering C.E., Belleville A., Benassi B., Leonetti C., Stevens M.F., D’Incalci M., Zupi G., Rizzo A., Elli R., Koering C.E., Belleville A., Benassi B., Leonetti C., Stevens M.F., D’Incalci M., Zupi G., Elli R., Koering C.E., Belleville A., Benassi B., Leonetti C., Stevens M.F., D’Incalci M., Zupi G., Koering C.E., Belleville A., Benassi B., Leonetti C., Stevens M.F., D’Incalci M., Zupi G., Belleville A., Benassi B., Leonetti C., Stevens M.F., D’Incalci M., Zupi G., Benassi B., Leonetti C., Stevens M.F., D’Incalci M., Zupi G., Leonetti C., Stevens M.F., D’Incalci M., Zupi G., Stevens M.F., D’Incalci M., Zupi G., D’Incalci M., Zupi G., Zupi G., et al. TRF2 inhibition triggers apoptosis and reduces tumorigenicity of human melanoma cells. Eur. J. Cancer. 2006;42:1881–1888. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous